Achieve Life Sciences, Inc. - Common Shares (ACHV)
NASDAQ · Healthcare
$6.24-0.48%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $643.67M
- P/E ratio
- —
- EPS
- —
- Volume
- 901,498
- 52-week high
- —
- 52-week low
- —
- Open
- $6.28
- Day high
- $6.42
- Day low
- $6.06
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$54.65M | -$1.25 |
| 2024 | — | -$39.83M | -$1.24 |
| 2023 | — | -$29.82M | -$1.50 |
| 2022 | — | -$42.35M | -$4.00 |
| 2021 | — | -$33.15M | -$4.08 |
About Achieve Life Sciences, Inc. - Common Shares
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engaging with nicotine receptors in the brain to lessen the intensity of nicotine withdrawal symptoms. The company holds licensing agreements with Sopharma AD and the University of Bristol. Its corporate headquarters are located in Vancouver, Canada.
- CEO
- Andrew D. Goldberg
- Employees
- 28
- Country
- US
- IPO date
- Oct 12, 1995
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Achieve Life Sciences, Inc. - Common Shares's stock price today?
- ACHV is trading at $6.24 as of Jul 20, 2026.
- What is Achieve Life Sciences, Inc. - Common Shares's market cap?
- Achieve Life Sciences, Inc. - Common Shares (ACHV) has a market capitalization of $643.67M.
- Does Achieve Life Sciences, Inc. - Common Shares pay a dividend?
- Achieve Life Sciences, Inc. - Common Shares did not pay a dividend in its most recent reported fiscal year.
- What sector is Achieve Life Sciences, Inc. - Common Shares in?
- Achieve Life Sciences, Inc. - Common Shares operates in the Healthcare sector.